258 related articles for article (PubMed ID: 27049562)
21. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life in patients with longstanding 'benign multiple sclerosis'.
Bueno AM; Sayao AL; Yousefi M; Devonshire V; Traboulsee A; Tremlett H
Mult Scler Relat Disord; 2015 Jan; 4(1):31-8. PubMed ID: 25787050
[TBL] [Abstract][Full Text] [Related]
23. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.
Amato MP; Ponziani G; Rossi F; Liedl CL; Stefanile C; Rossi L
Mult Scler; 2001 Oct; 7(5):340-4. PubMed ID: 11724451
[TBL] [Abstract][Full Text] [Related]
24. [Anxiety and Depression in Patients with Neuromyelitis Optica].
Miao XH; Shi ZY; Chen HX; Zhou HY; Yang R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):900-904. PubMed ID: 29260529
[TBL] [Abstract][Full Text] [Related]
25. Association of subcortical structural shapes with fatigue in neuromyelitis optica spectrum disorder.
Seok JM; Cho W; Son DH; Shin JH; Cho EB; Kim ST; Kim BJ; Seong JK; Min JH
Sci Rep; 2022 Jan; 12(1):1579. PubMed ID: 35091634
[TBL] [Abstract][Full Text] [Related]
26. Quality of life of patients with multiple sclerosis and neuromyelitis optica spectrum disorders: Cross-sectional and longitudinal analysis.
Kim S; Lee EJ; Kim KW; Seo D; Moon S; Kim KK; Lim YM
Mult Scler Relat Disord; 2022 Feb; 58():103500. PubMed ID: 35032884
[TBL] [Abstract][Full Text] [Related]
27. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
[TBL] [Abstract][Full Text] [Related]
28. [Correlates of Fatigue in Patients with Neuromyelitis Optica].
Chen HX; Shi ZY; Feng HR; Zhou HY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jul; 47(4):537-540. PubMed ID: 28591957
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of depression, anxiety, and sleep disturbances in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis.
Liu J; Zhang X; Zhong Y; Liu X
Mult Scler Relat Disord; 2023 Nov; 79():105007. PubMed ID: 37717305
[TBL] [Abstract][Full Text] [Related]
30. Neuromyelitis optica spectrum disorder: Patient experience and quality of life.
Beekman J; Keisler A; Pedraza O; Haramura M; Gianella-Borradori A; Katz E; Ratchford JN; Barron G; Cook LJ; Behne JM; Blaschke TF; Smith TJ; Yeaman MR
Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e580. PubMed ID: 31355316
[TBL] [Abstract][Full Text] [Related]
31. Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
Cho EB; Min JH; Cho HJ; Seok JM; Lee HL; Shin HY; Lee KH; Kim BJ
J Neurol Sci; 2016 Nov; 370():214-218. PubMed ID: 27772762
[TBL] [Abstract][Full Text] [Related]
32. Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
Masuda H; Mori M; Uzawa A; Uchida T; Ohtani R; Kuwabara S
PLoS One; 2020; 15(4):e0224419. PubMed ID: 32251416
[TBL] [Abstract][Full Text] [Related]
33. Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective: An Observational Cross-Sectional Study.
Meca-Lallana JE; Gómez-Ballesteros R; Pérez-Miralles F; Forero L; Sepúlveda M; Calles C; Martínez-Ginés ML; González-Suárez I; Boyero S; Romero-Pinel L; Sempere ÁP; Meca-Lallana V; Querol L; Costa-Frossard L; Prefasi D; Maurino J
Neurol Ther; 2022 Sep; 11(3):1101-1116. PubMed ID: 35524037
[TBL] [Abstract][Full Text] [Related]
34. Sleep disorders as a possible predisposing attack factor in neuromyelitis optica spectrum disorder (NMOSD): A case-control study.
Haji Molla Rabi S; Shahmirzaei S; Sahraian MA; Kazemi Mozdabadi RS; Rezaei Aliabadi H; Gheini MR; Majidi F; Naser Moghadasi A
Clin Neurol Neurosurg; 2021 May; 204():106606. PubMed ID: 33823399
[TBL] [Abstract][Full Text] [Related]
35. Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients.
Ayzenberg I; Richter D; Henke E; Asseyer S; Paul F; Trebst C; Hümmert MW; Havla J; Kümpfel T; Ringelstein M; Aktas O; Wildemann B; Jarius S; Häußler V; Stellmann JP; Senel M; Klotz L; Pellkofer HL; Weber MS; Pawlitzki M; Rommer PS; Berthele A; Wernecke KD; Hellwig K; Gold R; Kleiter I;
Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 34108267
[TBL] [Abstract][Full Text] [Related]
36. Fatigue, self-efficacy and psychiatric symptoms influence the quality of life in patients with myasthenia gravis in Tianjin, China.
Fan X; Xing C; Yang L; Wang J; Feng L
J Clin Neurosci; 2020 Sep; 79():84-89. PubMed ID: 33070925
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of cognitive function with intracranial lesions and the degree of depression and anxiety in patients with neuromyelitis optica spectrum disorders].
Zhong XL; Jia SS; Qiu F
Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):993-999. PubMed ID: 37528038
[No Abstract] [Full Text] [Related]
38. Eye movement abnormalities in AQP4-IgG positive neuromyelitis optica spectrum disorder.
Sun H; Cui S; Gao F; You Q; Li Y; Wang J; Zhang X
J Neurol Sci; 2018 Jan; 384():91-95. PubMed ID: 29249386
[TBL] [Abstract][Full Text] [Related]
39. Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders.
Schmidt F; Zimmermann H; Mikolajczak J; Oertel FC; Pache F; Weinhold M; Schinzel J; Bellmann-Strobl J; Ruprecht K; Paul F; Brandt AU
Mult Scler Relat Disord; 2017 Jan; 11():45-50. PubMed ID: 28104256
[TBL] [Abstract][Full Text] [Related]
40. Altered volume and microstructural integrity of hippocampus in NMOSD.
Chen X; Fu J; Luo Q; Han Y; Zheng Q; Xie M; Li Y
Mult Scler Relat Disord; 2019 Feb; 28():132-137. PubMed ID: 30594813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
